We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




New Test Identifies Positive Tuberculosis Cases Within the Hour

By LabMedica International staff writers
Posted on 27 Sep 2010
A new test can identify positive tuberculosis (TB) cases within one hour, ensuring quick treatment for patients and reducing the incidence and consequences of TB worldwide.

Researchers at the Health Protection Agency (HPA; London, United Kingdom) developed a new ultra rapid test for the TB bacteria, Mycobacterium tuberculosis, which substantially increases the sensitivity of the test, enabling detection of the presence of the bacteria in a sample within an hour. More...
The new technique is a single DNA molecule identification test, which uses real-time polymerase chain reaction (PCR).

The new test focuses on a particular DNA region within the TB bacterium, which the researchers say is present in all strains of the disease. According to the researchers, the test can pick up very small amount of bacteria, and appears to be as sensitive as the gold standard TB identification, a bacterial culture grown from mucus coughed up from the lungs. However, the standard test can take up to eight weeks to reach a diagnosis, by which time the individual might have infected many more people. The study findings were presented at the HPA's annual conference, held during September 2010 at the University of Warwick (United Kingdom).

"We're excited to have developed this new test because it means we can potentially diagnose someone at a TB clinic within an hour and start them immediately on the treatment they need,” said study author Catherine Arnold, Ph.D., head of the HPA's genomic services unit. "This new test could really have an impact where it is most needed.”

TB is a common and often deadly infectious disease that usually attacks the lungs, but can also affect other parts of the body. Most infections in humans result in an asymptomatic, latent infection, but about one in ten latent infections eventually progresses to active disease which, if left untreated, kills more than 50% of its victims. The World Health Organization (WHO, Geneva, Switzerland) has estimated that one third of the world's population carries TB bacteria, and recent years have seen resurgence in TB infections in developed countries, as well as the rise of strains resistant to medication.

Related Links:

Health Protection Agency
University of Warwick
World Health Organization


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Electrolyte Analyzer
BKE-B
Clinical Informatics Platform
CLARION™
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Nian Sun has spent years perfecting a device that he believes could change the way diseases are detected. (Photo courtesy of Alyssa Stone/Northeastern University)

Rapid Breath Sensor Detects SARS-CoV-2 from Exhaled Air

Nasal swabs and polymerase chain reaction (PCR) testing have been central to identifying SARS-CoV-2, but they can be uncomfortable, slow, and logistically complex when samples require transport.... Read more

Molecular Diagnostics

view channel
Image: At the MHH Institute of Human Genetics: Prof. Dr. Doris Steinemann, Dr. Bernardus Aldrige Allister and Prof. Dr Monika Golas (from left). (Image Credit: Karin Kaiser/MHH)

Multi-Omics Analysis Identifies Additional Risk Genes in Hereditary Breast and Ovarian Cancer

Hereditary breast and ovarian cancer can be difficult to explain genetically, leaving many high-risk families without clear answers. Although 13 established risk genes, including BRCA1 and BRCA2, are routinely... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.